Sales rise 12.02% to Rs 3.82 crore
Net Loss of Aspira Pathlab & Diagnostics reported to Rs 0.50 crore in the quarter ended March 2024 as against net loss of Rs 0.26 crore during the previous quarter ended March 2023. Sales rose 12.02% to Rs 3.82 crore in the quarter ended March 2024 as against Rs 3.41 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 2.67 crore in the year ended March 2024 as against net loss of Rs 0.09 crore during the previous year ended March 2023. Sales declined 8.71% to Rs 13.20 crore in the year ended March 2024 as against Rs 14.46 crore during the previous year ended March 2023.
ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales3.823.41 12 13.2014.46 -9 OPM %-3.144.40 --8.9411.07 - PBDT-0.120.12 PL -1.131.50 PL PBT-0.50-0.26 -92 -2.67-0.09 -2867 NP-0.50-0.26 -92 -2.67-0.09 -2867
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
